Oxford, United Kingdom

Graham Wynne


Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2009-2017

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Graham Wynne: Innovator in Pharmaceutical Compounds

Introduction

Graham Wynne is a notable inventor based in Oxford, GB, recognized for his contributions to the field of pharmaceutical compounds. With a total of four patents to his name, Wynne has made significant strides in developing innovative solutions for various medical conditions.

Latest Patents

Wynne's latest patents include groundbreaking work on quinoline compounds. These compounds have been shown to inhibit the formation of amyloid deposits, which are implicated in diseases such as type-2 diabetes and Alzheimer's disease. His second patent focuses on integrin antagonists that are useful as anticancer agents. This invention relates to compounds that can treat abnormal cell growth in mammals, showcasing Wynne's commitment to addressing critical health issues.

Career Highlights

Throughout his career, Wynne has worked with prominent organizations, including Osi Pharmaceuticals, Inc. and Oxford University Innovation Limited. His experience in these institutions has allowed him to refine his expertise and contribute to significant advancements in pharmaceutical research.

Collaborations

Wynne has collaborated with notable colleagues such as Jason Bloxham and Colin Peter Sambrook Smith. These partnerships have further enhanced his innovative capabilities and expanded the impact of his work.

Conclusion

Graham Wynne's contributions to the field of pharmaceutical compounds demonstrate his dedication to innovation and improving health outcomes. His patents reflect a deep understanding of complex medical challenges and a commitment to finding effective solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…